Tyra Biosciences, Inc.TYRANASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-103.66M
↓ 122% below average
Average (5y)
$-46.73M
Historical baseline
Range
High:$-3.11M
Low:$-103.66M
CAGR
+101.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-103.66M | -30.2% |
| 2023 | $-79.59M | -35.7% |
| 2022 | $-58.63M | -124.2% |
| 2021 | $-26.15M | -182.7% |
| 2020 | $-9.25M | -197.0% |
| 2019 | $-3.11M | - |